A vial of the Pfizer vaccine against the coronavirus disease (Covid-19) is seen as medical staff are vaccinated at Sheba Medical Center in Ramat Gan, Israel on Dec 19, 2020. A fourth dose of the Pfizer/BioNTech vaccine lowered rates of Covid-19 among the elderly but the protection against infection appeared short-lived, a large study in Israel...
Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, on June 24, 2021.Reuters A trial of Pfizer’s experimental antiviral pill for Covid-19 was stopped early after the drug was shown to cut by 89 per cent the chances of hospitalisation or death for adults at risk of developing severe disease, the...
The Pfizer/BioNTech vaccine is authorised for children as young as 12, and the companies are seeking authorisation for use in those as young as five years of age.Reuters WASHINGTON - The Pfizer/BioNTech Covid-19 vaccine was 93 per cent effective in preventing hospitalisations among those aged 12 to 18, according to an analysis released by the US Centres...
Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken Oct 31, 2020.Reuters Malaysia will procure an additional 12.8 million doses of coronavirus vaccine jointly developed by Pfizer and BioNTech in a bid to ramp up its...
The Pfizer candidate is a protease inhibitor that prevents the virus from replicating in cells.Reuters Pfizer has started an early-stage US trial of an oral Covid-19 antiviral therapy that could be prescribed to patients at the first sign of infection, the company said on Tuesday (March 23). The drugmaker, which developed the first authorised Covid-19 vaccine in...
